AR106146A1 - ANTI-TIGIT ANTIBODIES AND METHODS OF USE - Google Patents
ANTI-TIGIT ANTIBODIES AND METHODS OF USEInfo
- Publication number
- AR106146A1 AR106146A1 ARP160102929A ARP160102929A AR106146A1 AR 106146 A1 AR106146 A1 AR 106146A1 AR P160102929 A ARP160102929 A AR P160102929A AR P160102929 A ARP160102929 A AR P160102929A AR 106146 A1 AR106146 A1 AR 106146A1
- Authority
- AR
- Argentina
- Prior art keywords
- methods
- tigit
- tigit antibodies
- human tigit
- antibody
- Prior art date
Links
- 101000831007 Homo sapiens T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 abstract 3
- 102000049823 human TIGIT Human genes 0.000 abstract 3
- 101710090983 T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 abstract 1
- 102100024834 T-cell immunoreceptor with Ig and ITIM domains Human genes 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente solicitud se refiere a anticuerpos anti-TIGIT (inmunorreceptor de células T con dominios de Ig e ITIM) y métodos de uso de los mismos. Reivindicación 1: Un anticuerpo que se une específicamente a TIGIT humano caracterizado porque el anticuerpo se une a un epítope sobre TIGIT humano que comprende uno o más de los residuos de aminoácidos Ser78, Ser80, y Lys82 de TIGIT humano.The present application relates to anti-TIGIT antibodies (T-cell immunoreceptor with Ig and ITIM domains) and methods of use thereof. Claim 1: An antibody that specifically binds to human TIGIT characterized in that the antibody binds to an epitope on human TIGIT comprising one or more of the amino acid residues Ser78, Ser80, and Lys82 of human TIGIT.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562233230P | 2015-09-25 | 2015-09-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR106146A1 true AR106146A1 (en) | 2017-12-13 |
Family
ID=60931770
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160102929A AR106146A1 (en) | 2015-09-25 | 2016-09-26 | ANTI-TIGIT ANTIBODIES AND METHODS OF USE |
| ARP210100111A AR121189A2 (en) | 2015-09-25 | 2021-01-18 | ANTI-TIGIT ANTIBODIES AND METHODS OF USE |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210100111A AR121189A2 (en) | 2015-09-25 | 2021-01-18 | ANTI-TIGIT ANTIBODIES AND METHODS OF USE |
Country Status (1)
| Country | Link |
|---|---|
| AR (2) | AR106146A1 (en) |
-
2016
- 2016-09-26 AR ARP160102929A patent/AR106146A1/en unknown
-
2021
- 2021-01-18 AR ARP210100111A patent/AR121189A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR121189A2 (en) | 2022-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2021000716A1 (en) | Antibody constructs for flt3 and cd3. (divisional sol. 201800269) | |
| ZA202401297B (en) | Anti-tigit antibodies and methods of use | |
| CL2019003095A1 (en) | Anti-cd33 antibodies and methods of using them. | |
| CL2018000270A1 (en) | Antibody constructs for cd70 and cd3. | |
| CO2018010538A2 (en) | Specific poliovirus receptor (rvp) antibodies | |
| CL2019003093A1 (en) | Anti-trem2 antibodies and methods of using them. | |
| CL2018000267A1 (en) | Bispecific antibody constructs that bind dll3 and cd3 | |
| MX2019011927A (en) | Anti-ilt4 antibodies and antigen-binding fragments. | |
| MX2018003410A (en) | Humanized anti-human cd19 antibodies and methods of use. | |
| MX2024006565A (en) | PRO/LATENT ANTI-MYOSTATIN ANTIBODIES AND METHOD OF USE THEREOF. | |
| BR112021004316A2 (en) | Anti-Tren-2 Agonist Antibodies | |
| CL2018000378A1 (en) | Receptors of chimeric antigens based on single domain antibodies and methods of use of these | |
| CL2018000263A1 (en) | Bispecific antibody constructs that bind to egfrviii and cd3. | |
| ECSP17083779A (en) | IMMUNORECEPTOR BINDING AGENTS OF T-CELLS WITH GI DOMAINS AND INHIBITION MOTIVES BASED ON IMMUNORECEPTOR TYROSINE (TIGIT) AND USES THEREOF | |
| MX2017012802A (en) | ANTISORTILINE ANTIBODIES AND METHODS FOR USE. | |
| UY36245A (en) | ANTIBODY CONSTRUCTS FOR CDH19 AND CD3 | |
| CR20160338A (en) | ANTIBODIES AND METHODS OF USE | |
| MX2020002395A (en) | METHODS TO EVALUATE ANTIBODIES AND DRUG CONJUGATES. | |
| MX2015009819A (en) | SPECIFIC HUMAN ANTIBODY TO HUMAN METAPNEUMOVIRUS, OR FRAGMENT OF UNION TO THE ANTIGEN OF THE SAME. | |
| AR106146A1 (en) | ANTI-TIGIT ANTIBODIES AND METHODS OF USE | |
| AR113854A1 (en) | ANTI-CXCR5 ANTIBODIES, COMPOSITIONS AND USES THEREOF | |
| AR133026A2 (en) | Antibody constructs for DLL3 and CD3 | |
| AR115312A1 (en) | C-TERMINAL ANTIBODY VARIANTS | |
| AR105316A1 (en) | ANTIBODIES AGAINST THE TRANSFERRINE RECEIVER (ANTI-CD71), ANTI-CD71 ACTIVABLES ANTIBODIES AND THEIR METHODS OF USE |